Sign in

CIK 0001125345

  • Non-accelerated filer
  • Smaller reporting company

MACROGENICS INC

Sign in to watch
Ticker
MGNX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 301-251-5172
Business address
9704 MEDICAL CENTER DRIVE, Rockville, MD, 20850
  1. 4 Derivatives Options or other derivatives
  2. 4 Open-market sale Director sold 6,924 shares at $29.38 ($203,427)
  3. 4 Open-market sale General Counsel sold 68 shares at $30.00 ($2,040)
  4. 4 Open-market sale Sr VP, BPD & Manufacturing sold 1,770 shares at $30.00 ($53,100)
  5. 4 Exercise or conversion Sr VP & Chief Business Officer acquired 6,000 shares (option exercise)
  6. 4 Exercise or conversion SVP, CFO and Secretary acquired 7,326 shares (option exercise)
  7. 4 Exercise or conversion SVP, CFO and Secretary acquired 5,314 shares (option exercise)
  8. 4 Exercise or conversion President and CEO acquired 39,897 shares (option exercise)
  9. 4 Exercise or conversion SVP, CFO and Secretary acquired 5,000 shares (option exercise)
  10. 4 Exercise or conversion Sr VP & Chief Business Officer acquired 5,000 shares (option exercise)
  11. 4 Exercise or conversion SVP, CFO and Secretary acquired 3,000 shares (option exercise)
  12. 4 Exercise or conversion Sr VP & Chief Business Officer acquired 4,000 shares (option exercise)
  13. 4 Exercise or conversion President and CEO acquired 40,000 shares (option exercise)
  14. 4 Exercise or conversion Sr VP & Chief Business Officer acquired 3,000 shares (option exercise)
  15. 3 Insider Initial Statement of Ownership
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 14 of 25 · 484 filings